Corcept Therapeutics COPT Investor Presentation July 2024

Corcept Therapeutics discovers, develops, and commercializes medications that treat severe diseases by modulating cortisol effects. The presentation outlines the company's pipeline of selective cortisol modulators including relacorilant, dazucorilant, and miricorilant, along with regulatory strategies and commercialization plans.